Page last updated: 2024-11-06

triethylenemelamine and Marchiafava-Micheli Syndrome

triethylenemelamine has been researched along with Marchiafava-Micheli Syndrome in 1 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRIDGES, JB1
BRIDGES, JM1
EDELSTYN, GJ1
LYONS, AR1

Other Studies

1 other study available for triethylenemelamine and Marchiafava-Micheli Syndrome

ArticleYear
FEOTAL LIVER SUSPENSIONS IN THE TREATMENT OF MARROW APLASIA.
    British journal of cancer, 1965, Volume: 19

    Topics: Anemia; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Fetus; Hemoglobi

1965